2021 PepTalk Keynote Presentations:

TUESDAY, JANUARY 19

Characterization of Biotherapeutics Carrying Synonymous Mutations

Chava Kimchi-Sarfaty, PhD, Deputy Associate Director for Research, Office of Tissues and Advanced Therapies, CBER, FDA


New Methods for Cell-Free Presentation of Proteins for Functional Analysis

Joshua LaBaer, PhD, Executive Director, Arizona State University Biodesign Institute


Rise of the Machines: Optimizing Workflows for Compatibility with Automation

Sarah M. Rue, PhD, Associate Director, Advanced Automation Technologies, Genomics Institute of the Novartis Research Foundation


Analysis of New Therapeutic Modalities: Challenges, Opportunities, and New Methods

Sunny Zhou, PhD, Professor, Chemistry & Chemical Biology, Northeastern University


WEDNESDAY, JANUARY 20

Expeditious Discovery and Evaluation of Bispecific Antibody Formats for Cancer Therapy

Harald Kolmar, PhD, Professor and Head, Institute for Organic Chemistry and Biochemistry, Technische Universität Darmstadt


History and Application of Biological Standardisation to Biological Products, and Relevance to ATMP

Christopher Bravery, PhD, Consulting Regulatory Scientist, Consulting on Advanced Biologicals Ltd.


Continuous Precipitation – Microfiltration for Initial Purification of Monoclonal Antibodies

Andrew Zydney, PhD, Bayard D. Kunkle Chair & Professor, Chemical Engineering, Pennsylvania State University


THURSDAY, JANUARY 21

Structure and Characterization of Monoclonal Antibody Self-Association Complex Reveals Specific Face-to-Face Interaction: Developability and Predictive Implications

Carl Mieczkowski, PhD, Associate Principal Scientist, Protein Sciences, Merck Research Labs


Rise of the Machines: Optimizing Workflows for Compatibility with Automation

Sarah M. Rue, PhD, Associate Director, Advanced Automation Technologies, Genomics Institute of the Novartis Research Foundation